🇺🇸 Phlebotonic in United States

15 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Aphasia — 2 reports (13.33%)
  2. Cerebral Artery Thrombosis — 2 reports (13.33%)
  3. Cerebral Infarction — 2 reports (13.33%)
  4. Ischaemic Stroke — 2 reports (13.33%)
  5. Overdose — 2 reports (13.33%)
  6. Abdominal Pain — 1 report (6.67%)
  7. Anaemia — 1 report (6.67%)
  8. Aortic Aneurysm Rupture — 1 report (6.67%)
  9. Cerebral Artery Occlusion — 1 report (6.67%)
  10. Clonus — 1 report (6.67%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Phlebotonic approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Phlebotonic in United States?

Italfarmaco is the originator. The local marketing authorisation holder may differ — check the official source linked above.